Preliminary in vivo studies, on exposing healthy Swiss albino mice to VnNp demonstrated normal blood parameters, organ distribution, and tissue redox balance which further indicated the absence of any adverse organ toxicity. Hence, we foresee tumor-targeting VnNp as a potential drug molecule for future cancer management.
Vanadium is a trace element in the human body playing important roles in the normal functioning of the thyroid gland, 1,2 maintaining calcium homeostasis, 3 glycemic balance, 1, 4 and helps in fat metabolism 5 . However, the exact role and mechanism of action in the human body are not fully understood. Vanadium enters the body through natural food sources such as mushroom, soybean, black pepper, various seafoods such as shellfish and sea cucumber. 1, 6 Vanadium exists in many forms, like, sodium orthovanadate (Na3VO4), vanadyl sulphate (VOSO4.xH2O), sodium metavanadate (NaVO3) and vanadium pentoxide (V2O5). 7 Vanadium sulfate is found to elicit insulin-mimetic activity 8 and is also used as a nutritional supplement by athletes for building muscle mass. 8 Bulk vanadium has proven to have a higher affinity towards adipose tissue 9 and hence exploited in understanding the possibility of using the same for breast cancer management without the help of any additional targeting. Moreover, it is proven in a case-controlled human study that vanadocene complex treatment in women significantly reduced the chances of breast cancer development 10 . However, the exact mechanism behind the anticancer property of this complex on breast cancer and its overall influence on subcellular organelles, cells, tissues and organisms are yet to elucidate.
Cancer cells rapidly undergo mutations such that they develop resistance to the conventional anti-cancer drug molecules, which emerge as a severe point of concern in cancer management.
Developing nanomedicine through the rational design of nanomaterials could address this issue.
With the advancements in synthesis and characterization techniques, engineered nanostructures have become popular in a variety of biomedical applications like nanomedicine 11 , bioimaging [12] [13] [14] as well as in various other theranostic applications [15] [16] [17] . Some of the previously reported intracellular effects of nanomaterials include the generation of oxidative stress 18 and induction of autophagy 19, 20 . Also, most of the nanomaterials exhibit concentration-dependent structural and functional alterations in various biomolecules like lipids, carbohydrates, proteins, DNA 21 and even affect cellular organelles. These events modulate the cell death pathway by involving lysosomal dysfunction 22 , mitochondrial damage 23, 24 , etc.
However, detailed studies on the exact fate of nanomaterials within the cells and its nano-bio interaction studies are still lagging. Due to the lack of such in-depth reviews, nanomedicine has not yet matured from its infancy even after a research history of many decades. Based on this knowledge and existing knowledge gaps, we have investigated the specific activity of vanadium nanoparticles on breast cancer cells within well-controlled biological systems. We hope that an in-depth understanding of the effect of vanadium nanoparticles on breast cancer cells could help to engineer newer generations of nanoformulations, thereby enabling nanoparticle-mediated cancer management.
Results
Synthesis and characterization. The synthesis of vanadium nanoparticles followed a hydrothermal route. Subsequently, characterized for understanding its physical, chemical, and morphological properties. Transmission electron microscopy (TEM) revealed the spherical morphology of the synthesized vanadium nanoparticles (VnNp) with an average particle size of 50 nm (Fig. 1a ). Energy dispersive x-ray (EDX) analysis confirmed that the sample contained only vanadium and oxygen without any traces of impurities (Fig. 1b) . The x-ray powder diffraction (XRD) pattern confirmed the monocrystalline, orthorhombic sherrebanite structure for VnNp following the PDF 00-041-1426 data ( Fig. 1c & Supplementary Fig. 1a ). Two predominant peaks observed at 20 and 26 degrees represented the preferred orientation of atoms along 001 and 110 planes of the crystal structure. The binding energies obtained from x-ray photoelectron spectroscopy (XPS) at 517 eV and 530 eV correlated to the V2p3/2 and O1s electronic orbitals respectively. These binding energies were characteristic of the +5 oxidation state of the sample ( Fig.1d & Supplementary Fig. 1b ). Raman spectral (RS) analysis showed the typical bending vibrations of O-V=O at 143, 282, and 406 cm −1 . The stretching vibrations observed at 692 and 995 cm −1 denoted doubly coordinated oxygen in V=O and the terminal unshared oxygen atom in V-O respectively (Fig. 1e ). Infrared (IR) spectroscopy also revealed specific metal-oxygen stretching and bending modes complementing the Raman data. Peaks observed at 1014, 846 and 671 cm −1 represented V=O stretching, O-V vibrations and asymmetric and symmetric stretching modes in V-O-V bridging respectively ( Supplementary Fig. 1c ). VnNp showed weak absorbance at 430 nm in the UV-visible spectrum ( Supplementary Fig. 1d ) which is in agreement with earlier reported value 25 and noted a surface charge of -13 MeV through the zeta potential analysis. Supplementary Fig. 2a ). Intracellularly sequestered VnNps were observed as distinct small aggregates within the cellular cytoplasm ( Fig. 2c ) upon 4h of treatment. On to the weak optical property and the high electron density of VnNp, TEM has been used to understand the cellular uptake and cell-material interactions visually. Raman spectral mapping of VnNp treated cells at 4h also demonstrated a characteristic peak of vanadium-oxygen stretching vibrations at 995 cm -1 (Fig. 2b) confirming VnNp uptake. Further, flow cytometry analysis of 50 μM VnNp treatment at 4h showed a typical shift in the side scatter pattern (SSC) owing to the increased cellular granularity which could be due to efficient VnNp uptake ( Fig. 2d & e ). The higher rates of VnNp uptake by cancer cells could be due to the higher levels of metabolic activity of these cells. Meanwhile, the L929 cells failed to show such a change in the SSC area ( Supplementary Fig. 2b ) where the cells experienced reduced levels of VnNp uptake explaining the observed less cell death pattern in the MTT assay. The drastic difference noted in cell response between healthy and cancer cells for the same concentrations of VnNp intensified the quest for further investigations to prove its suitability for breast cancer management. Based on these results, the interaction of an optimum level of 50 µM or lower concentrations of VnNp on MDA-MB-231 cells were further investigated in detail. VnNp mediated in vitro cellular response. Nanoparticles, once they are in the cytoplasm, often known to stimulate a variety of stress response reactions such as activation of autophagy, ROS generation, etc. These stress responses could result in organelle damage leading to cell death 26 . Autophagy could also be elicited as a cell's pro-survival mechanism to meet the nutritional requirements of cells at times of nutritional deficiency or other stress cues. This process involves digesting its own damaged organelles such as mitochondria to enable nutrient recycling. During autophagy, autophagosomes are formed with the involvement of an essential Autophagy, a dynamic process was evaluated using a quantitative flux assay, which allowed a comparison between the levels of LC3-I and II proteins at a given time. Western blot analysis also revealed the accumulation pattern of LC3-II protein in response to VnNp treatment further substantiating autophagy induction ( Fig. 3c) . A lysosomotropic reagent, chloroquine was utilized for the assay which inhibited autophagosome-lysosome fusion by blocking LC3-II degradation, thereby allowing autophagosome accumulation. A two-fold increase in the LC3-II protein levels was observed in the vanadium-chloroquine co-treated cells, indicating autophagy induction by 4h of treatment ( Fig. 3d ). The expression levels of LC3 protein analyzed until 24 h indicated a visual increase in the LC3-II levels in all the test samples, in comparison with the 24 h untreated and starvation controls ( Supplementary Fig. 3 ). The electron micrographs of VnNp treated cells further identified the presence of cytoplasmic organelles within the autolysosomes (a hallmark of autophagy) which added confirmation of autophagy induction at 4h of treatment ( Fig. 3e ).
Autophagosomes end up fusion with the lysosomes (Fig. 3e ) degrading its contents including damaged organelles to meet the energy requirements of the cells. The phago-lysosomal fusion resulted in increased lysosomal size, identified through acid vesicle specific LysoTracker® Red, which further supported autophagy induction in VnNp, exposed cells. (Fig. 4c ). These acidic vesicles were found to exhibit a pattern accumulation near the peri-nuclear region to maintain the high acidity of organelle associated with VnNp treatment as evident from the electron micrographs ( Fig. 4d ). A 10 fold increase in the fluorescence intensity was observed in the treated cells compared to the control cell population ( Fig. 4e) , which indicated increased lysosomal acidification. Here, the occurrence of large acidic vesicles could be due to incomplete lysosomal degradation or defective lysosomal recycling. Increased lysosomal size could elevate its surface tension leading to membrane disruption and subsequent release of acidic contents into the cytosol. However, it was interesting to note that this has not happened, as no acidic membrane disruption was observed even after 48 h of treatment ( Fig. 4c ). To confirm further, the lysosomal membrane integrity was analyzed using acridine orange (AO), a highly selective metachromatic fluorochrome. Sharp spots of red fluorescence were observed from the VnNp treated cells throughout the study period until 48 h of incubation, indicating intact lysosomal membrane architecture ( Supplementary Fig. 4 ). Together, these findings suggest that even though VnNp treatment led to phagolysosomal accumulation and increased acidic vesicles, they did not elicit lysosomal membrane disruption. However, such a condition could lead to the onset of various cellular stress response reactions in treated cells such as ROS generation. Under normal physiological conditions, ROS in cells is tightly regulated by the strong interplay between various mitochondrial enzymes involved in redox signaling pathways. These proteins facilitate normal homeostasis and protect cells from oxidative stress-induced damage. However, ROS inducers overpass this protective machinery, damage mitochondrial membrane potential, and induce oxidative stress. Hence, the mitochondrial membrane potential (Δψm) was quantitatively evaluated using flow cytometry with a fluorescent probe, JC10. A positive control, carbonyl dichlorofluorescein diacetate (DCFDA) assay. The cells in the VnNp treated group showed approximately 30% decrease in ROS levels at an initial 4h incubation period in comparison with their untreated control population. However, the ROS pattern reversed with a significant increase in green fluorescence towards 24 h treatment in comparison with the corresponding untreated controls ( Fig. 5d & e ). VnNp mediated reduction in superoxide levels in cells at initial time points was quite unexpected, and hence mechanism behind this was investigated in the cell-free system. Accordingly, the rate of inhibition of pyrogallol auto-oxidation in the presence of VnNp was checked and found a 7% reduction within the initial 10 minutes of incubation ( Supplementary Fig. 5 ). This is attributed to the ability of VnNp to inhibit superoxide formation or accelerated neutralization of oxy-radicals. Subsequently, a much more sensitive Amplex ® Red assay was executed to check specifically the levels of H2O2, in MDA-MB-231 cells to confirm the efficacy of VnNp to act as antioxidants or pro-oxidants against intrinsic levels of ROS. This assay also clearly indicated an initial decline in the amplex red fluorescence intensity pattern which further established that VnNp is responsible for the initial decline in the H2O2 levels in vitro ( Fig. 5f ). Nonetheless, the levels of H2O2 elevated towards 24 h treatment in a similar pattern as that was observed in the DCF assay. (Fig. 6c & 6d) . Also, the electron micrographs depicted leaky nuclear membrane morphology in cells that are exposed to 50 μM of VnNp for 48 h (Fig. 6e) Fig. 7 & 8) . Various apoptotic cellular events were also marked through membrane blebbing ( Fig. 7b & Supplementary Fig. 8 ) nuclear membrane disruption ( Fig. 6e) and nuclear fragmentation ( Supplementary Fig. 9 ) all supportive of the apoptotic mode of cell death towards 48h of VnNp treatment. Through this study, a systematic mechanistic insight is given on how triple-negative breast cancer cells behave towards the VnNp treatment with an initial attempt of unaccomplished cell survival, finally resulting in cell death. We also tried to understand whether VnNp inhibits breast cancer cell migration in vitro through a wound-healing assay in MDA-MB-231 cells maintained in minimal FBS to prevent cell proliferation. Interestingly, it was observed that the wound did not patch even after 72h of treatment with 12.5, 6.25 and 3.125 µM VnNp. Conversely, the control group covered up the patch through enhanced cell migration towards the wounded area within 72 h (Fig. 7c ). Hence, we are optimistic that VnNp could inhibit breast cancer cell metastasis, which is yet another critical area of concern to be addressed in its management. A colonogenic assay also exhibited the potential of VnNp to inhibit colony formation (Fig. 7d ) which further proved its potential to inhibit tumor growth in vitro.
VnNp mediated in vivo response. Nanoparticles largely influence the external environmental
conditions to which they have been exposed. Hence, we tried to understand the fundamental (Fig. 8a) . The possible chances of accumulation of VnNp in the excretory organs were further evaluated using elemental analysis with inductive coupled plasma optical emission spectroscopy (ICP -OES). A quantitative measure on the residual levels of vanadium in the vital organs like liver, kidney and spleen was evaluated. The liver samples indicated 0.014 parts per million (ppm), 0.065 ppm and 0.036 ppm of vanadium in the 1, 3 and 21-day post-treatment samples (Fig. 8b) . The levels were maximum in the day-3 sample indicating the possibility of its persistence in the blood until deposition and the levels declined towards day-21 which attribute towards particle elimination. The spleen samples showed traces of vanadium, with 0.017 ppm towards day-21 ( Fig. 8c ) while none of the kidney samples showed detectable levels of vanadium at any of the periods. In addition, blood analysis studies revealed elevated WBC levels in the treatment group in comparison with the untreated control population, which could be attributed to the presence of traces of vanadium in the spleen.
Various other hematology and biochemical parameters like creatinine, urea, aspartate aminotransferase (AST) & alanine aminotransferase (ALT) levels were comparable to that of controls in the 21-day samples (Fig. 8d ). This reflected normal blood parameters including liver and kidney function marker proteins between the treated and untreated groups. Very interestingly, a statistically significant decrease in cholesterol levels was observed in the 21-day sample in comparison with the control group which could be correlated to the anti-lipidemic activity of vanadium, known from ancient times. As this point needs further investigations and is not under the scope of the present study, no further investigations were done in this regard.
Like the in vitro studies on the real-time levels of stress response mRNA, the pattern of SOD's and catalase from liver, kidney, and spleen were also analyzed to monitor the extent of nanomaterial induced stress responses, in vivo. The transient mRNA levels of these genes specify the redox status of organs involved in the elimination process. The low levels of SOD1, 2, 3 and catalase mRNA in the day-1 liver samples indicated no immediate stress response in the liver (Fig. 8e ). An increase in levels of all the 3 SOD's and catalase mRNA was observed towards day 3, indicating delayed response towards VnNp treatment. Interestingly, it was found that all these mRNA levels dropped back to normal by day-21 in liver samples (Fig. 8e) . This observation points out that despite the presence of traces of VnNp within the liver even after 21 days following a single dose exposure, the organs still maintained a healthy redox balance, hepatic and renal function. The kidney samples showed a rise in the mRNA levels of all the three SOD's and catalase in the day-1 sample which was found subsided indicating the absence of any delayed stress response in the kidneys (Fig. 8f) and thus proved the renal safety aspects of VnNp. Even though in kidney samples, an initial increase in SOD mRNAs was observed, the process was also dealt with enormous catalase levels involved in detoxifying any H2O2 produced during the first-day post-treatment. The relative levels of SOD's and catalase in spleen samples also indicated basal redox mRNA levels by the end of 21-day of post-exposure ( Fig. 8g) indicating the absence of VnNp induced stress response in the spleen. In summary, it can be deduced from these results that the presence of VnNp in none of the excretory organs elicited any stress response. These results were again confirmed with the histopathology observation ( Supplementary Fig. 9 ). The tissue sections obtained from the untreated and VnNp treated samples showed similar tissue organization in the liver and kidney, while the 21-day spleen samples showed elevated levels of lymphocyte infiltration, which could be a reason for high levels of WBC observed in the blood studies. In addition, VnNp efficiently blocked cell migration and tumor growth in vitro. Further, the in vivo murine experimental analysis with VnNp administration revealed normal mRNA levels of stress response genes in the liver and spleen. Also, the treatment neither caused tissue damage nor affected their function even after three weeks of a single shot tail vein injection. Thus, the study provides a mechanistic understanding of the interaction of VnNp in vitro and in vivo, as a platform for the development and design of vanadium-based nanotherapeutics for breast cancer management, thereby strengthening the need for detailed material interaction studies for biomedical applications. The study is an attempt towards developing a promising nanovanadium-based anticancer agent, and can be modified for future application as a promising anticancer molecule with extensive studies on tumor-bearing animal models to validate their potential to be used in nanomedicine. Measure of oxidative balance. The rate of inhibition on Pyrogallol auto-oxidation in the presence of VnNp was performed through kinetic studies with UV-1800 Shimadzu UV-Vis spectrophotometer in a cell-free system. The protocol was adopted from the improved pyrogallol assay experiment.
Materials and Methods

Synthesis and characterization of
Reactive oxygen species (ROS) in cells subsequent to VnNp exposure were measured using H2DCFDA reagent (Invitrogen cat# C6827). Cells were seeded on a 96 well culture plate at an initial seeding density of 2x10 4 cells/well and allowed to grow overnight. The VnNp treatment followed a similar treatment concentration as that of MTT assay and 10 μM H2O2 treatment for 20 minutes served as positive controls. The assay was performed as per the manufacturer's instructions. The ROS levels from untreated cells maintained under ambient conditions were taken into account in order to normalize treatment values and readings from wells with all the said reagents and vanadium except cells were obtained to minimize the background interference and to normalize the readings. The fluorescence intensity was analyzed in a 96-well spectrofluorimeter plate reader (Synergy H1 hybrid multi-mode microplate reader, Bio-
Tek) at an excitation and emission wavelength of 492 and 527 nm respectively.
Qualitative cellular fluorescence images captured with an Olympus Fluorescence
Microscope (IX83, Tokyo, Japan).
The specific levels of H2O2 produced in cells treated with VnNp were monitored using an Amplex assay red kit from Invitrogen and followed the manufacturer's instructions. 
